Oligonucleotides Targeting Telomeres and Telomerase in Cancer

被引:42
作者
Schrank, Zachary [1 ]
Khan, Nabiha [1 ]
Osude, Chike [1 ]
Singh, Sanjana [1 ]
Miller, Rachel J. [1 ]
Merrick, Collin [1 ]
Mabel, Alexander [1 ]
Kuckovic, Adijan [1 ]
Puri, Neelu [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA
关键词
T-oligo; GRN163L; miRNA; imetelstat; telomere; telomerase; DNA-DAMAGE RESPONSES; DOUBLE-STRANDED-RNA; T-OLIGO; IN-VITRO; INHIBITOR IMETELSTAT; LUNG-CANCER; PHASE-II; MECHANISM; GRN163L; INDUCTION;
D O I
10.3390/molecules23092267
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Telomeres and telomerase have become attractive targets for the development of anticancer therapeutics due to their involvement in cancer cell immortality. Currently, several therapeutics have been developed that directly target telomerase and telomeres, such as telomerase inhibitors and G-quadruplex stabilizing ligands. Telomere-specific oligonucleotides that reduce telomerase activity and disrupt telomere architecture are also in development as novel anticancer therapeutics. Specifically, GRN163L and T-oligos have demonstrated promising anticancer activity in multiple cancers types via induction of potent DNA damage responses. Currently, several miRNAs have been implicated in the regulation of telomerase activity and may prove to be valuable targets in the development of novel therapies by reducing expression of telomerase subunits. Targeting miRNAs that are known to increase expression of telomerase subunits may be another strategy to reduce carcinogenesis. This review aims to provide a comprehensive understanding of current oligonucleotide-based anticancer therapies that target telomeres and telomerase. These studies may help design novel therapeutic approaches to overcome the challenges of oligonucleotide therapy in a clinical setting.
引用
收藏
页数:16
相关论文
共 87 条
[1]   Nonviral delivery of synthetic siRNAs in vivo [J].
Akhtar, Saghir ;
Benter, Ibrahim F. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3623-3632
[2]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]   Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells [J].
Aoki, Hiroshi ;
Iwado, Eiji ;
Eller, Mark S. ;
Kondo, Yasuko ;
Fujiwara, Keishi ;
Li, Guang-Zhi ;
Hess, Kenneth R. ;
Siwak, Doris R. ;
Sawaya, Raymond ;
Mills, Gordon B. ;
Gilchrest, Barbara A. ;
Kondo, Seiji .
FASEB JOURNAL, 2007, 21 (11) :2918-2930
[4]   Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies [J].
Babizhayev, Mark A. ;
Yegorov, Yegor E. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2015, 103 (12) :3993-4023
[5]   Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer [J].
Bertorelle, R. ;
Briarava, M. ;
Rampazzo, E. ;
Biasini, L. ;
Agostini, M. ;
Maretto, I. ;
Lonardi, S. ;
Friso, M. L. ;
Mescoli, C. ;
Zagonel, V. ;
Nitti, D. ;
De Rossi, A. ;
Pucciarelli, S. .
BRITISH JOURNAL OF CANCER, 2013, 108 (02) :278-284
[6]   A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer [J].
Bianchi, Fabrizio ;
Nicassio, Francesco ;
Marzi, Matteo ;
Belloni, Elena ;
Dall'Olio, Valentina ;
Bernard, Loris ;
Pelosi, Giuseppe ;
Maisonneuve, Patrick ;
Veronesi, Giulia ;
Di Fiore, Pier Paolo .
EMBO MOLECULAR MEDICINE, 2011, 3 (08) :495-503
[7]   Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells [J].
Burchett, Katrina M. ;
Etekpo, Asserewou ;
Batra, Surinder K. ;
Yan, Ying ;
Ouellette, Michel M. .
ONCOTARGET, 2017, 8 (48) :83754-83767
[8]   Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells [J].
Burchett, Katrina M. ;
Yan, Ying ;
Ouellette, Michel M. .
PLOS ONE, 2014, 9 (01)
[9]   Telomere Dynamics in Mice and Humans [J].
Calado, Rodrigo T. ;
Dumitriu, Bogdan .
SEMINARS IN HEMATOLOGY, 2013, 50 (02) :165-174
[10]   miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo [J].
Chakrabarti, Mrinmay ;
Banik, Naren L. ;
Ray, Swapan K. .
EXPERIMENTAL CELL RESEARCH, 2013, 319 (10) :1575-1585